What is TRICCAR, Inc. (TCCR) stock price today?

TRICCAR, Inc. (TCCR) is currently trading at $1.50, up 23.97% today.

What is TCCR P/E ratio?

TRICCAR, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is TCCR return on equity (ROE)?

TRICCAR, Inc.'s return on equity (ROE) is 427.32%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

OTC · Biotechnology

TRICCAR, Inc. (TCCR) Stock

$1.50 +23.97% OTC: TCCR Healthcare

TRICCAR, Inc. delivers essential saltwater disposal services, primarily catering to the oil and gas industry.

Valuation

Metric	Value
Price	$1.50
Market Cap	$0
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$1.60
52-Week Low	$1.50
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	427.32%
ROA	-280.40%
ROCE	277.00%
Gross Margin	18.27%
Operating Margin	-82.20%
Net Margin	-169.09%
Debt/Equity	-1.14
Current Ratio	0.42

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$1.0M	$1.0M	$1.0M	$0	$0
Operating Profit	$-1.0M	$-1.0M	$-4.0M	$0	$0
Net Profit	$-1.0M	$-1.0M	$-4.0M	$0	$0
EPS	$-0.11	$-0.06	$-0.29	$0.00	$0.00
Op Margin	-91.5%	-78.0%	-429.9%	—	-76.4%

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$4.0M	$3.0M	$0	$0	$0
Total Liabilities	$11.0M	$11.0M	$0	$0	$0
Cash	$0	$0	$0	$0	$0
Borrowings	$8.0M	$8.0M	$0	$0	$0

Latest News

US judge dismisses criminal case against Indian billionaire Adani Reuters Videos · Aug 11, 2026 Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know StockStory · Aug 11, 2026 Manulife Appoints Jeremy Young as Chief Distribution Officer, International Brokerage, Global High-Net-Worth to Advance Growth Strategy Across Key Markets PR Newswire · Aug 11, 2026 Extreme heat is reshaping Italy's sparkling wine industry with early harvests and nighttime picking Associated Press · Aug 11, 2026 /C O R R E C T I O N -- Frontera Energy Corporation/ PR Newswire · Aug 11, 2026

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$0	$0	$0	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$0	$0	$0	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.37
FCF Yield	-9383.24%
Quick Ratio	0.42
Interest Coverage	-0.64
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BSTGBiostage, Inc.	$4.03	+0.75%	-9.83	$57.82M	0.00%
DMTTFSmall Pharma Inc.	$0.11	-9.69%	-2.20	$37.51M	0.00%
HITCHealthcare Integrated Technologies, Inc.	$0.30	+0.00%	-5.86	$52.84M	0.00%
HRPMFHerantis Pharma Oyj	$3.51	+0.00%	-6.09	$59.47M	0.00%
MCIOFMCI Onehealth Technologies Inc.	$0.55	-1.10%	-1.31	$54.04M	0.00%

About TRICCAR, Inc.

TRICCAR, Inc. delivers essential saltwater disposal services, primarily catering to the oil and gas industry. The company supports hydrocarbon producers by providing a crucial solution for managing the saline wastewater that results from their extraction operations. All disposal activities take place at specialized wells situated in Wise County, Texas, while TRICCAR's corporate base is located in Shreveport, Louisiana.

the stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.50 and $1.60, and currently trades 6.3% below its 52-week high.

On profitability, TRICCAR, Inc. generates a return on equity (ROE) of 427.32% — well above the market average, a sign of a high-quality business, return on capital employed of 277.00%, an operating margin of -82.20%, a net profit margin of -169.09%.

Official website: www.triccar.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides